Global Cancer Targeted Therapy Market Data Survey Report 2025

Table of Contents

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of Application
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

2 Regional Market

• 2.1 Regional Production
• 2.2 Regional Demand
• 2.3 Regional Trade

3 Key Manufacturers

• 3.1 Advaxis
  • 3.1.2 Company Information
  • 3.1.2 Product Specifications
  • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.2 Bind Therapeutics
  • 3.2.1 Company Information
  • 3.2.2 Product Specifications
  • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.3 Boehringer Ingelheim
  • 3.3.1 Company Information
  • 3.3.2 Product Specifications
  • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.4 Bristol Mayer Squibb
  • 3.4.1 Company Information
  • 3.4.2 Product Specifications
  • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.5 Celldex Therapeutics
  • 3.5.1 Company Information
  • 3.5.2 Product Specifications
  • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.6 Dendreon Corporation
  • 3.6.1 Company Information
  • 3.6.2 Product Specifications
  • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.7 Dendreon Corporation
  • 3.7.1 Company Information
  • 3.7.2 Product Specifications
  • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.8 GalaxoSmithKline
  • 3.8.1 Company Information
  • 3.8.2 Product Specifications
  • 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.9 Galena Biopharma
  • 3.9.1 Company Information
  • 3.9.2 Product Specifications
  • 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.10 Genetech
  • 3.10.1 Company Information
  • 3.10.2 Product Specifications
  • 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.11 ImmunoCellular Therapeutics
• 3.12 ImmunoGen
• 3.13 Inovio Pharmaceuticals
• 3.14 Johnson & Johnson
• 3.15 NeoStem Oncology
• 3.16 NewLink Genetics
• 3.17 Northwest Biotherapeutics
• 3.18 Merck
• 3.19 Novartis
• 3.20 Peregrine Pharmaceuticals
• 3.21 Pfizer
• 3.22 Roche
• 3.23 Sanofi
• 3.24 Seattle Genetics
• 3.25 Teva

4 Major Application

• 4.1 Hospital
  • 4.1.1 Overview
  • 4.1.2 Hospital Market Size and Forecast
• 4.2 Clinic
  • 4.2.1 Overview
  • 4.2.2 Clinic Market Size and Forecast
• 4.3 Others
  • 4.3.1 Overview
  • 4.3.2 Others Market Size and Forecast

5 Market by Type

• 5.1 Tumor Antigens As Targets of Antibodies
  • 5.1.1 Overview
  • 5.1.2 Tumor Antigens As Targets of Antibodies Market Size and Forecast
• 5.2 Development of Antibodies for Clinical Purposes
  • 5.2.1 Overview
  • 5.2.2 Development of Antibodies for Clinical Purposes Market Size and Forecast
• 5.3 Complement Dependent Cytotoxicity (CDC)
  • 5.3.1 Overview
  • 5.3.2 Complement Dependent Cytotoxicity (CDC) Market Size and Forecast
• 5.4 Signal Transduction Changes
  • 5.4.1 Overview
  • 5.4.2 Signal Transduction Changes Market Size and Forecast

6 Conclusion